$AYI

HOLCOM KAREN J sold $629K of AYI

HOLCOM KAREN J (SVP & Chief Financial Officer) sold 2,076 shares of ACUITY INC. (DE) (AYI) at $303.14 ($0.63M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HOLCOM KAREN J
Published Jun 3, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AYI
Neutral
medium confidence
Mentioned
$AYI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AYINeutralLow
01

Why it matters

The disclosure provides incremental information about insider liquidity/positioning but lacks new operational or financial developments.

02

Market read

Traders may monitor for patterns in insider activity, but this specific transaction is scheduled and therefore lower-signal.

03

What to watch

The filing date is after the trade date; traders should avoid over-interpreting timing versus actual execution.

Relevance 6/10Novelty 6/10Timing: Filed June 3; sale executed June 1 (10b5-1 open-market).

Background

SEC Form 4 reports an officer’s transaction in the company’s own shares; this filing notes a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$AYINeutralMedium confidence
Context

Acuity Brands CFO Karen Holcom sold 2,076 shares in an open-market transaction disclosed via SEC Form 4 on June 1, 2026.

Expected impact

Limited near-term impact; any reaction is likely small and short-lived unless accompanied by other fundamental news.

Evidence & confidence

Form 4 shows a scheduled 10b5-1 sale with no accompanying earnings/guidance or deal information, so it’s more of a positioning datapoint than a catalyst.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst stated.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • ACUITY INC. (DE)

    Subject of the insider transaction disclosure; CFO sold shares under a 10b5-1 plan.

  • HOLCOM KAREN J

    SVP & Chief Financial Officer who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNHighAI 8/10

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

$AYIMedAI 8/10

AYI Q3 Deep Dive: Margin Expansion Outpaces Revenue Growth Amid Mixed Top-Line Results

Acuity Brands (AYI) reported Q3 revenue of $1.24B, up 2.9% YoY, missing estimates but exceeding EPS expectations with $5.77 per share. Management highlighted margin expansion in lighting and growth in Intelligent Spaces, offset by softer lighting market performance. Future challenges include higher memory costs, while opportunities lie in new verticals and innovation.

$AYIMedAI 8/10

Acuity (AYI) Stock Slips As AIS Gains Meet Memory Cost Pressure

Acuity (AYI) stock fell 3.4% to $299.28, despite Q4 revenue growth of 2.9% and EPS increase of 55.4%. Acuity Intelligent Spaces (AIS) grew to 25% of revenue, boosting margins. However, memory cost pressures and flat ABL sales raised concerns. Net income rose 51.8% to $173.0M, with net profit margin improving to 11.4%.

$AYIHighAI 8/10

Acuity (AYI) Q4 2026 Earnings Call Transcript

Acuity Brands (AYI) reported Q4 2026 net sales of $4.6B, up 6.8% YoY, driven by its intelligent spaces portfolio. Adjusted EPS rose 11% to $5.77, while gross margin expanded 130 bps to 50.2%. The lighting segment saw a 0.4% sales decline, while intelligent spaces grew 16.6%. Fiscal 2027 guidance: $4.7B-$4.9B revenue, $20.50-$22.00 EPS. The company repurchased $287M in shares and fully repaid QSC acquisition debt.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.